当前诊断工具在医疗保健工作者中检测潜在结核病的性能:系统性审查
Aishwarya R1, Maheshwary D1, Leela Kv1
1Microbiology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Chengalpattu, IND.
Cureus
|November 1, 2024
概括
本综述比较了医疗保健工作者潜在结核病感染的诊断测试. CLIA-IGRA显示了最高的准确性,但TST和QuantiFERON在特定情况下仍然是有价值的.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 潜在结核病感染 (LTBI) 诊断对于预防活跃结核病至关重要,特别是在医疗保健工作者等高风险群体中.
- 干扰素释测试 (IGRA) 和曼图克斯/结核素皮肤测试 (TST) 是LTBI的关键诊断工具.
- 对测试特征的系统评估有助于诊断,特别是在资源有限的环境中.
研究的目的:
- 系统地评估和比较各种潜在肺结核感染 (LTBI) 测试的诊断准确性,特别是在医疗保健工作者中.
- 确定2013年至2024年期间发表的研究,重点关注该人群中LTBI诊断.
主要方法:
- 系统性审查遵循系统性审查和元分析 (PRISMA) 2020指南的首选报告项目.
- 使用关键词进行文献搜索:"潜伏结核病"",医疗保健工作者"",诊断方式"",TST"",干扰素-释测试"和"IGRA".
- 由三位作者撰写的独立文献评论,差异通过讨论解决.
主要成果:
- 克利亚-伊格拉显示出最高的诊断准确性,具有100%的灵敏度和95.57%的特异性 (AUC=0.97).
- T-SPOT.TB显示了92%的灵敏度和95.7%的特异性 (AUC=0.7).
- TST的灵敏度为76.5%和特异性为77.2% (AUC=0.72),而QuantiFERON-TB Gold In-Tube (QFT-GIT) 的灵敏度为68.35%和特异性为82.32% (AUC=0.767).
结论:
- CLIA-IGRA是对医疗保健工作者进行LTBI诊断的高度准确的测试,尽管可用性和成本可能会限制其使用.
- TST和QuantiFERON测定仍然是相关和有用的诊断工具,特别是当它们的性能与临床需求和资源可用性保持一致时.
- 选择LTBI诊断测试应该考虑准确性,实用性和特定人口要求之间的平衡.
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
305
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212
Pneumonia III: Complications and Assessment
172
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
172


